Aster DM Healthcare (NSE:ASTERDM, BOM:540975) has received board approval to acquire 20.25% additional stake in its subsidiary, Malabar Institute of Medical Sciences (MIMS), according to a Thursday filing to the Indian stock exchanges.
The company has plans to increase its shareholding in MIMS from 79.75% to 100% from its existing shareholders at the rate of 202 Indian rupees each.
The transaction is to be completed within three months.
The company's shares were down over 2% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments